Absci is trading 10.59% up now at $10.86, with no clear company-specific catalyst identified for September 22, 2026.

  • The latest notable item is an updated September 16 Morgan Stanley healthcare-conference presentation discussing ABS-201 interim data, not a new announcement today.
  • The Nasdaq Composite is up only 0.40%; the move may reflect positioning or speculative trading.